Kiniksa(US:KNSA) Globenewswire·2025-10-23 20:01Core Viewpoint - Kiniksa Pharmaceuticals International, plc will host a conference call on October 28, 2025, to discuss its third quarter 2025 financial results and recent portfolio execution [1]. Group 1: Conference Call Details - The conference call is scheduled for 8:30 a.m. Eastern Time on October 28, 2025 [1]. - A live webcast will be available on the company's website, and participants can register for telephone access [2]. - A replay of the event will be accessible on Kiniksa's website approximately 48 hours after the call [2]. Group 2: Company Overview - Kiniksa is a biopharmaceutical company focused on developing therapies for debilitating diseases, particularly in cardiovascular indications [3]. - The company aims to address unmet medical needs through its portfolio, which is based on strong biological rationale and validated mechanisms [3].